Literature DB >> 16497410

Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung.

Takamoto Saijo1, Genichiro Ishii, Kanji Nagai, Kazuhito Funai, Junichi Nitadori, Koji Tsuta, Michiya Nara, Tomoyuki Hishida, Atsushi Ochiai.   

Abstract

The central type and peripheral type squamous cell carcinoma (SCC) of the lung have different clinicopathological characteristics, but, little is known about their biological characteristics. We investigated differences between the properties and phenotypes of peripheral-type (P-type) and central-type (C-type) SCC by performing an immunohistochemical analysis of each type by tissue microarray analysis with a large panel of antibodies. To examine strictly, we selected 20 P-type SCCs that were pathological stage T1 and limited to more peripherally than the fifth bronchial bifurcation, and 21 C-type SCCs that were pathological stage T1 and limited to a lobar bronchus. The results of the clinicopathological study showed that the patients with P-type SCC were significantly older than the patients with C-type SCC and that squamous metaplasia was predominant in C-type SCC than in P-type SCC. The 36 antibodies revealed different expression patterns of cytokeratin 7 (CK 7) and cytokeratin 19 (CK 19) between C-type and P-type SCC. CK 7 expression was more predominant in P-type SCC than in C-type SCC, and CK 19 expression was more predominant in C-type SCC than in P-type SCC. These results suggest that C-type and P-type SCC have different clinicopathological and biological features.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497410     DOI: 10.1016/j.lungcan.2005.12.006

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  6 in total

1.  Differing histopathology and prognosis in pulmonary adenocarcinoma at central and peripheral locations.

Authors:  Youngkyu Moon; Kyo Young Lee; Sook Whan Sung; Jae Kil Park
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

2.  Choice of the surgical approach for patients with stage I lung squamous cell carcinoma ≤3 cm.

Authors:  Chunji Chen; Yiyang Wang; Xufeng Pan; Shijie Fu; Yubo Shi; Jun Yang; Rui Wang
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

3.  Comprehensive investigation of clinicopathologic features, oncogenic driver mutations and immunohistochemical markers in peripheral lung squamous cell carcinoma.

Authors:  Yang Zhang; Difan Zheng; Yuan Li; Yunjian Pan; Yihua Sun; Haiquan Chen
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

4.  Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.

Authors:  Shengteng Shao; Guisong Song; Yuanyong Wang; Tengfei Yi; Shuo Li; Fuhui Chen; Yang Li; Xiaotong Liu; Bin Han; Yuhong Liu
Journal:  Front Oncol       Date:  2022-08-23       Impact factor: 5.738

5.  Peripheral type squamous cell carcinoma of the lung: clinicopathologic characteristics in comparison to the central type.

Authors:  Yeoun Eun Sung; Uiju Cho; Kyo Young Lee
Journal:  J Pathol Transl Med       Date:  2020-06-17

6.  Integrated evaluation of clinical, pathological and radiological prognostic factors in squamous cell carcinoma of the lung.

Authors:  Kyowon Gu; Ho Yun Lee; Kyungjong Lee; Joon Young Choi; Sook Young Woo; Insuk Sohn; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Jae Ill Zo; Young Mog Shim
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.